HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Siraganian, R. P. Articles by Siragania, P. A. Search for Related Content PubMed Articles by Siraganian, R. P. Articles by Siragania, P. A.

Mechanism of Action of Concanvalin A on Human Basophils¹

From the Clinical Immunology Section, Laboratory of Microbiology and Immunology, NIDR, National Institutes of Health, Bethesda, Maryland 20014

Abstract

Concanavalin A (Con A) activates human basophils to release histamine. This reaction has great similarities to that of antigen-or anti-IgE-induced release. It is characterized by a two stage reaction: the initial stage is the binding of Con A to the cell and the second stage is a secretory process of the cell. Cells desensitized by incubation with excess amounts of Con A or by prolonged incubation in the absence of cations cannot be activated to release with antigen or anti-IgE. When the native (tetravalent) Con A molecule is modified by succinic anhydride to become divalent it is much less active in releasing histamine.

There is wide variation in the response of cells from different individuals to Con A. However, a close correlation exists between the histamine release induced by Con A and anti-IgE. Therefore, in general, cells from allergic donors release more histamine with Con A than those from non-allergic individuals.

Evidence is presented to demonstrate that Con A acts by binding to carbohydrate groups on the IgE molecule located on the basophil membrane. On a molar basis, IgE is 4000-fold more active than -methyl-D-mannoside in inhibiting the Con A-induced histamine release. Succinyl Con A blocks the ability of Con A and anti-IgE equally well and to a lesser extent the ability of antigen to activate cells to release histamine.

Footnotes

¹ Part of this investigation was completed at the Public Health Research Institute of New York, Inc., New York, New York and was supported by Grant AI-10455 from the United States Public Health Service.